Industry News
Study finds new treatment target for aggressive blood cancer
1/13/2015
Acute myeloid leukaemia is an aggressive blood cancer with a poor prognosis. Now, fresh clues about a molecular mechanism in the disease may offer a new drug target.
Skin cancer : new mechanism involved in tumour initiation, growth and progression
1/13/2015
Squamous cell carcinoma (SCC) represents the second most frequent skin cancer with more than half million new patients affected every year in the world.
Lung cancer: Phase III data for Gilotrif (afatinib) published in The Lancet Oncology
1/13/2015
Boehringer Ingelheim has announced overall survival (OS) results were published in The Lancet Oncology from two independent Phase III clinical trials (LUX-Lung 3 and LUX-Lung 6) in epidermal growth...
Stomach cancer is diagnosed in around 80,000 people in the European Union (EU) each year1 and is associated with a very poor prognosis.
Erbitux (cetuximab), in combination with FOLFIRI or FOLFOX, has been recommended for use within NHS Scotland by the Scottish Medicines Consortium (SMC) for the first line treatment of metastatic...
Skin cancer : new mechanism involved in tumour initiation, growth and progression
1/13/2015
Squamous cell carcinoma (SCC) represents the second most frequent skin cancer with more than half million new patients affected every year in the world.
Wound-induced skin cancer may be fueled by bacteria
1/13/2015
Researchers at King's College London have identified a new mechanism by which skin damage triggers the formation of tumours, which could have important therapeutic implications for patients suffering...
Favorable OS rates for rectal cancer patients demonstrated by secondary analysis of RTOG 0247
1/13/2015
Locally advanced rectal cancer patients who receive preoperative radiation therapy with either irinotecan plus capecitabine or oxaliplatin plus capecitabine have a four-year overall survival rate of...
Cancer biopsies do not promote cancer spread
1/13/2015
A study of more than 2,000 patients by researchers at Mayo Clinic's campus in Jacksonville, Florida, has dispelled the myth that cancer biopsies cause cancer to spread.
Tumor-blocking role found for cell regulation molecule
1/13/2015
In order to develop new anti-cancer treatments, researchers need to identify target molecules that are responsible for controlling tumour growth.